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Introduction
Several studies, for quite a number of years
now, have demonstrated the importance of the role of
segmental duplications in the field of chromosome
pathologies. Segmental duplications are blocks of
few low copy repeats(LCRs) that recognize a recip-
rocal homology higher than 90% in non-homologous
200 to 400 kb chromosome segments. They account
for about 6% of the human genome and are inter-
spersed through the genome, but especially located
in the pericentromeric, thelomeric and subthelomeric
regions. They can include a large number of genes ,
but can also include broken non-processed pseudo-
genes. Segmental duplications are often duplicated in
one chromosome region at a reciprocal distance of a
few megabases (less than 10 Mb) and they mediate a
possible non allelic homologous recombination,
NAHR, between chromosomes or between sister
chromatids: this may result in unequal crossing-over
or in chromosome rearrangements and is, therefore,
the basis of frequent and specific mechanisms of
structural chromosome mutations such as micro-
deletions or micro-duplications, but also transloca-
tions, inversions and marker chromosomes. Micro-
deletions are more frequent than micro-duplication,
as widely stated in scientific literature. Micro-dele-
tions can in fact originate from a wide range of
recombination mechanisms and can be intra-chro-
matid, inter-chromatid or intra-chromosomal, where-
as micro-duplications can only originate from an
inter-chromatid or intra-chromosomal recombina-
tions(1,2).
The advent of array-CGH with its high image
definition (it can detect chromosomal anomalies
even lower than 50 kb) paves the way for an easier
mapping of such submicroscopic genomic variants
(micro-deletions or micro-duplications), increasing
the possibility of a correct diagnosis. The introduc-
tion of array-CGH also represents a significant
advancement in the diagnosis of individuals with a
“chromosomal phenotype” (mental retardation, dys-
morphic features, congenital anomalies)(3-7) and nor-
mal karyotype. All these conditions play a very
important role in determining morbidity and mortali-
ty rates, especially in neonatal age, when many other
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risk factors (prematurity(8,9), twinning, nosocomial
infections(10,11,12,13), chemical mediators(14,15)) may add
their cumulative effect influencing short- and long-
term outcome. No less than 15-20 % of the patients
with mental retardation, dysmorphic features, con-
genital anomalies, and normal karyotype are carriers
of a cryptic chromosomal unbalance sometimes as
extended as 100 kb, not detected by the classic cyto-
genetic techniques(16,17,18,19,20,21).
Undoubtedly array-CGH allows ever more
accurate and precise analyses with greater simplicity
and faster response(22,23,24,25,26,27,28). In the present study
we discuss how the same chromosomal region can
be affected by deletion or by duplication, respective-
ly responsible for a syndrome (type) and for a
counter-syndrome (counter-type), with different
phenotypic manifestations.
22q11.2
Region q 11.2 of chromosome 22 shows eight
LCRs organized in clusters (4 thelomeric ones and 4
centromeric ones, called LCR 22s ). Namely, a dele-
tion of 3 Mb is the cause of a DiGeorge/velo-cardio-
facial syndrome, while a reciprocal interstitial dupli-
cation characterizes both CES (cat eye syndrome)
and dup22, precisely a tetrasomy in the first and a tri-
somy in the second(29,30). Analyzing the phenotype
features we can see how deletion and duplication
occurring in the same region 22q11.2 (included
TBX1 gene) can actually determine two distinct syn-
dromes with different courses and prognoses, so that
we can define the 22q11.2 micro-duplication syn-
drome as a “countersyndrome” or a “countertype” of
the 22q11.2 micro-deletion syndrome(31,32). In fact,
the clinical picture leading to or hinting at a micro-
deletion syndrome diagnosis is more frequently an
occurrence of multiple congenital anomalies (gener-
ally cardiac conotruncal defects, cleft palate,
velopharingeal insufficiency, tonsillar hypertrophy,
dental anomalies), convulsions and tremors due to
neonatal hypocalcaemia, a typical facies, recurrent
infections due to immune deficiency and thymus
aplasia, and psychomotor and/or language retarda-
tion, hypothyroidism and behavioral disorder(33,34). On
the other hand, the most frequent features of a
22q11.2 micro-duplication syndrome are a varying
degree of mental retardation/learning difficulties,
attention defect and hyperactivity, hearing impair-
ment, language disorder, psychomotor retardation,
growth delay, low muscle tone, epileptic
seizures(35,36,37,38,39). Comparing the features in either
syndrome we can notice that facial dysmorphic fea-
tures variably present in 22q11.2 micro-duplication
syndrome are different and often slighter than those
of a 22q11.2 micro-deletion syndrome.
17 p11.2
Region 11.2 of arm p of chromosome 17 is
sided with three “proximal” “middle” and “distal”
copies of “low copy repeats (LCR)” also known as
“SMS-REPs” (Smith-Magenis repeats). In particu-
lar, an interstitial deletion of about 3.7 Mb deter-
mines a Smith-Magenis syndrome, whereas an
interstitial reciprocal duplication is the cause of a
Potocky-Lupsky syndrome(40). Analyzing the pheno-
type described in literature we can observe that the
Potocky-Lupsky syndrome shows different, slighter
and less severe clinic and phenotypic features than
the Smith-Magenis syndrome. Such phenotypic
diversity allows us to define the Potocky-Lupsky
syndrome as a “counter-syndrome” or a “counter-
type” of the Smith-Magenis syndrome, even if they
both share the same genomic region and also sever-
al genes, among which the RAI-1 gene (retinoic
acid 1 inductor) mainly responsible for the pheno-
typic manifestations in both syndromes. We can in
fact, observe that, apart from delayed growth, cog-
nitive and language deficiency, hyperactive or
attention defects, EEG alterations, variably present
though with different degrees of severity in both
syndromes the most important features of the
Potocky-Lupsky syndrome are: low muscle tone,
scarce feeding and delayed growth in infancy,
oropharyngeal dysphagia, dental issues, autistic dis-
orders, central and obstructive sleep apnoea, car-
diac anomalies, EEG alterations, hypermetropia,
lower blood cholesterol, obsessive compulsive dis-
orders. In addition, in the Potocki-Lupski syn-
drome, variable dysmorphic features may be vari-
ably present, including triangular face, frontal boss-
ing, microcephaly, hypertelorism, wide nasal
bridge, epicantal folds, flat philtrum(41).
On the contrary, in the Smith-Magenis syn-
drome, we can variably and frequently observe:
cerebral malformations, peripheral neuropathy,
epileptic seizures, markedly dysmorphic features,
hypercholesterolemia, self-destructive or aggressive
behaviors, important sleep disturbances, obesity,
otorhinolaryngologic auditory and ophthalmologic
anomalies, renal and genitourinary anomalies,
skeletal and digital anomalies.
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16 p11.2
It has been noticed in a recent study that
9.89% (7.8 Mb) of chromosome 16 shows segmen-
tal duplications. Analyzing the phenotype described
in literature(42,43) we can see that a 16p11.2 micro-
duplication syndrome shows less serious clinical
and phenotypic features with respect to a 16p11.2
micro-deletion syndrome. It is therefore possible to
point out that both a 16p11.2 micro-duplication
syndrome and a 16p11.2 micro-deletion syndrome
share phenotypic features such as delayed growth,
delayed language development, learning difficul-
ties, cognitive disability, low muscle tone. While
the micro-deletion syndrome provokes an increased
tendency to overweight and obesity, a possible
association between 16p11.2 micro-duplication and
reduced weight and reduced body mass index has
been argued.
In fact, deletion of the region 16p11.2 seems
to be associated with overweight and obesity liabili-
ty, due to haploinsufficiency of SH2B1 gene, which
is involved in leptin and insulin signaling. Micro-
deletion is more frequently associated with macro-
cephaly while microduplication with microcephaly.
It is argued, besides, that micro-deletion might
more often be associated with delayed linguistic
and cognitive development, with minor dysmorphic
facial features without a consistent pattern, with
autistic disorders, and with minor cardiac malfor-
mations, hemivertebrae and syringoyelia, while
micro-duplication is associated with psychiatric
problems such as bipolar disorder, depression, psy-
chotic disturbance , schizophrenia.
Discussion
It is possible to highlight the differences
between the phenotypic and neuro-behavioural
manifestations of deletions and those of the recipro-
cal and complementary duplications in the same
chromosomal region, especially as regards severity,
frequency and recurrence. It must be noticed that
the phenotypical appearance of both syndromes is
often extremely variable with several degrees of
severity.
Therefore micro-duplications, with respect to
micro-deletion, show a slighter and milder clinical
picture, sometimes even near normality, so that it is
not always easy to recognize and identify such an
anomaly. The identification of cryptic chromosome
anomalies by means of modern molecular tech-
niques, in particular array-CGH, has enabled physi-
cians to devise follow-up programs intended to pre-
vent the associated clinical problems.
We can conclude that array-CGH might
become a means to fill the present gap between the
knowledge of the human genome and the function
of its genes: it is evident that any “de novo” dele-
tion/duplication associated with a specific malfor-
mation or syndrome suggests that, among the genes
located in the region studied, at least one is respon-
sible for that malformation and for that syndrome,
either due to aplo-insufficiency (deletion or type or
syndrome) or to an excessive dosage (duplication or
counter-type or counter-syndrome).
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